Impact of COVID-19 & Response Measures on HIV-HCV Prevention Services and Social Determinants in People Who Inject Drugs in 13 Sites with Recent HIV Outbreaks in Europe, North America and Israel.  Wiessing L, Sypsa V, Abagiu AO, Arble A, B…

Disruptions to U.S. local public health's role in population-based substance use prevention and response during COVID-19.  Hall K, Higgins F, Beach KF, Diriba K, Sladky M, McCall TC.  Subst Abuse Treat Prev Policy. 2022 Nov 7;17(1):73. d…

Nothing really changed: Arizona patient experience of methadone and buprenorphine access during COVID.  Meyerson BE, Bentele KG, Russell DM, Brady BR, Downer M, Garcia RC, Garnett I, Lutz R, Mahoney A, Samorano S, Arredondo C, Andres HJ, Coles…

Innovations, adaptations, and accelerations in the delivery of HIV services during COVID-19 Murphy, Eamonn et al. The Lancet HIV, Volume 0, Issue 0  https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(22)00268-5/fulltext

Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 Pandemic.  Frost MC, Zhang L, Kim HM, Lin LA.  JAMA Netw Open. 2022 Oct 3;5(10):e2236298. doi: 10.1001/jamanetwor…

Drugs and alcohol Use patterns among those seeking care in urban rehabilitation centres before and during early months of COVID-19 in Uganda.  Tumwesigye NM, Ocama P, Basangwa D, Matovu F, Abbo C, Wamala T, Biribawa C, Namanda C, Blessing J, T…